Friday, July 03, 2020 2:42:54 PM
Here, let me help get you started.
~~ Per your own words. ~~
{“Low side affects with historical Data on positive outcomes with patients lungs who have pneumonia RVVTF Bucillamine drug is going to be a game changer for tens of millions of people around the world. Billion dollar market cap in the making don't listen to these experts who can't read chart and nothing about a drugs value on treatment for Covid-19. These people are here to steal your shares.”}
{“price target $10.00 by end of summer. My friend is a Pharma analyst at Goldman Sachs. He says if Approval on RVVTF Bucillamine comes for Covid-19. At hits current market cap. The price valuations will between $20.00-$30.00.”}
{“Anything under .50 is a gift.
Multi Dollars in the coming weeks and months.”}
{“Don't sell for pennies sell for double digit dollars!”}
{“I hope people hold up for double digit dollars. Depending on how many shares you own. People will be able to retire with a nice chunk of cash in the bank. I think we see $10.00-$20.00 Plus by Q1 2021 5000% ROI from todays currents levels.”}
{“We are sitting on a goldmine here.”}
{“$3.00-$4.00 by the end of summer.”}
{“Fortunes to be made here on RVVTF.”}
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM